文献速递炎症性肠病

韩国儿童与成人起病炎症性肠病的抗肿瘤坏死因子-α治疗模式与预后:全国性人群基础研究

Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-07-06

该全国性人群基础研究基于韩国罕见难治性疾病诊断代码识别炎症性肠病(IBD),计算儿童与成人发病率与患病率,描述抗肿瘤坏死因子(anti-TNF)处方模式,并用Cox比例风险模型分析手术风险。结果显示儿童克罗恩病(CD)患病率从2006年12.7例/10万人增至2015年35.5例/10万人,儿童CD抗TNF使用从3.2%升至22.9%,早期使用增加25倍;0-14岁CD患者行瘘管切除术风险最高(HR 2.63,95%CI 1.73-3.97),儿童溃疡性结肠炎(UC)手术风险高于成人(HR 3.01,95%CI 1.33-6.83),CD早期使用抗TNF与较低手术几率相关。

要点

  • 儿童CD患病率从2006年12.7例/10万人升至2015年35.5例/10万人。
  • 儿童CD抗TNF使用从3.2%升至22.9%,早期使用增加25倍。
  • 0-14岁CD患者瘘管切除术风险HR 2.63(95%CI 1.73-3.97)。

核心结论

  • IBD患病率随时间增加,尤其在儿童患者中。
  • 鉴于儿童IBD疾病负担的规模,需要多方面的策略来实现早期发现和警惕性监测以追求更好的预后。

研究设计与样本

  • 全国性人群基础研究,基于韩国罕见难治性疾病诊断代码识别克罗恩病(CD)和溃疡性结肠炎(UC)。
  • 计算年龄别患病率和发病率,检查处方模式,并使用Cox比例风险模型计算手术风险比(HR)。

主要发现

  • CD患病率在2006年至2015年间增加,尤其在10-19岁年龄组(从12.7例/10万人增至35.5例/10万人)。
  • 儿童CD患者抗TNF药物使用从3.2%增至22.9%。
  • CD患者早期使用抗TNF药物增加25倍。
  • 0-14岁CD患者最可能行瘘管切除术(HR 2.63;95%CI 1.73-3.97)。
  • 儿童UC患者手术风险高于成人(HR 3.01;95%CI 1.33-6.83),CD患者早期使用抗TNF与较晚期使用相比手术几率更低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The global prevalence of inflammatory bowel disease (IBD) is increasing. However, population-level data are scarce for Asian populations. AIMS: To outline and compare paediatric and adult IBD incidence and prevalence data in Korea, describe prescription patterns, and analyse outcomes of anti-tumour necrosis factor (anti-TNF) use in a nationally representative cohort METHODS: IBD was identified based on the presence of Rare and Intractable Disease diagnosis codes for Crohn's disease (CD) and ulcerative colitis (UC). We calculated age-based prevalence and incidence, and examined prescription patterns. We used a Cox proportional hazard model to calculate the hazard ratio (HR) for undergoing surgery. RESULTS: The prevalence of CD increased between 2006 and 2015, particularly among those aged 10-19 years (12.7-35.5 patients per 100,000 people). The use of anti-TNF agents increased from 3.2% to 22.9% in paediatric CD patients. Early use of an anti-TNF agent increased 25-fold in CD patients. Further, CD patients aged 0-14 years were most likely to undergo fistulectomy (HR, 2.63; 95% confidence interval [CI], 1.73-3.97). Children with UC had a higher risk of undergoing surgery (HR, 3.01; 95% CI, 1.33-6.83) than adults. Early use of an anti-TNF agent in CD patients was associated with lower odds of surgery than late-stage use. CONCLUSION: The prevalence of IBD has increased over time, especially among paediatric patients. Given the magnitude of paediatric IBD disease burden, a multi-faceted approach is needed for early detection and vigilant monitoring to aim for better prognosis.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Choe YJ, Han K, Shim JO, et al. Treatment patterns of anti-tumour necrosis factor-alpha and prognosis of paediatric and adult-onset inflammatory bowel disease in Korea: a nationwide population-based study. Aliment Pharmacol Ther. 2022. PMID: 35791668. doi:10.1111/apt.17125

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。